JESSICA ERIM: Open Payments
NPI 1093479339 · LEESBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,353 in 55 payments from 18 companies in 2025. Trend: 2023 $900 · 2024 $1,097 · 2025 $1,353
Food & beverage: $1,353
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $309 |
| ABBVIE INC. | 12 | $273 |
| Amgen Inc. | 8 | $173 |
| Lilly USA, LLC | 4 | $75 |
| PFIZER INC. | 3 | $68 |
| Astellas Pharma US Inc | 2 | $58 |
| Otsuka America Pharmaceutical, Inc. | 3 | $58 |
| Noah Medical Corporation | 1 | $53 |
| Dexcom, Inc. | 1 | $40 |
| Vanda Pharmaceuticals Inc. | 1 | $35 |
Products named: OTEZLA, QULIPTA, Wegovy, VRAYLAR, Ozempic, Veozah, REXULTI, GALAXY.
Industry payments across VA — which companies pay providers there.
